ATE362490T1 - Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung - Google Patents

Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung

Info

Publication number
ATE362490T1
ATE362490T1 AT01912086T AT01912086T ATE362490T1 AT E362490 T1 ATE362490 T1 AT E362490T1 AT 01912086 T AT01912086 T AT 01912086T AT 01912086 T AT01912086 T AT 01912086T AT E362490 T1 ATE362490 T1 AT E362490T1
Authority
AT
Austria
Prior art keywords
production
monoclonal antibodies
antibodies against
ldl receptor
human ldl
Prior art date
Application number
AT01912086T
Other languages
English (en)
Inventor
Nachum Yonah
Dany Suissa
Ilana Belzer
Moshe Smolarsky
Francesco Antonetti
Michel Dreano
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE362490(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL13502500A external-priority patent/IL135025A0/xx
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE362490T1 publication Critical patent/ATE362490T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01912086T 2000-03-13 2001-03-08 Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung ATE362490T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13502500A IL135025A0 (en) 2000-03-13 2000-03-13 Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use

Publications (1)

Publication Number Publication Date
ATE362490T1 true ATE362490T1 (de) 2007-06-15

Family

ID=26323933

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01912086T ATE362490T1 (de) 2000-03-13 2001-03-08 Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung

Country Status (33)

Country Link
US (1) US6849720B2 (de)
EP (1) EP1263790B1 (de)
JP (1) JP4768193B2 (de)
KR (1) KR100882081B1 (de)
CN (1) CN1418225B (de)
AR (1) AR028518A1 (de)
AT (1) ATE362490T1 (de)
AU (2) AU4100201A (de)
BG (1) BG65762B1 (de)
BR (1) BR0109164A (de)
CA (1) CA2402593C (de)
CY (1) CY1108020T1 (de)
CZ (1) CZ20023098A3 (de)
DE (1) DE60128452T2 (de)
DK (1) DK1263790T3 (de)
EA (1) EA007494B1 (de)
EE (1) EE200200517A (de)
ES (1) ES2282238T3 (de)
HK (1) HK1055750A1 (de)
HR (1) HRP20020704B1 (de)
HU (1) HU226194B1 (de)
IL (2) IL139217A0 (de)
MX (1) MXPA02009091A (de)
NO (1) NO330904B1 (de)
NZ (1) NZ520944A (de)
PL (1) PL206041B1 (de)
PT (1) PT1263790E (de)
RS (1) RS51406B (de)
SI (1) SI1263790T1 (de)
SK (1) SK287348B6 (de)
UA (1) UA78489C2 (de)
WO (1) WO2001068710A1 (de)
ZA (1) ZA200206654B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
US7598046B2 (en) 2003-06-19 2009-10-06 Laboratories Serono Sa Use of prion conversion modulating agents
FR2889533B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
FR2889532B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
EP1991869A2 (de) * 2006-02-17 2008-11-19 Paolo La Colla Verfahren zur diagnose von proliferations- und/oder konformationskrankheiten
FR2910896B1 (fr) * 2006-12-29 2012-11-16 Lab Francais Du Fractionnement Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en) 2007-05-03 2008-01-20 Yeda Res & Dev Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) * 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
WO2011147863A1 (en) 2010-05-25 2011-12-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
WO2013024157A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of host targeting agents for the treatment and the prevention of hcv infection
WO2013024155A1 (en) 2011-08-17 2013-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
CN103111270B (zh) * 2013-02-26 2015-06-10 王业富 一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182364A (en) * 1990-02-26 1993-01-26 The Scripps Research Institute Polypeptide analogs of apolipoprotein E
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP2000279174A (ja) * 1999-03-30 2000-10-10 Bml Inc ヒトｌｄｌレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

Also Published As

Publication number Publication date
CA2402593C (en) 2012-07-03
BG107063A (bg) 2003-05-30
RS51406B (sr) 2011-02-28
JP4768193B2 (ja) 2011-09-07
NO20024223D0 (no) 2002-09-04
NO330904B1 (no) 2011-08-15
CA2402593A1 (en) 2001-09-20
AU2001241002B2 (en) 2006-04-06
BR0109164A (pt) 2002-11-26
KR20020089384A (ko) 2002-11-29
AU2001241002B8 (en) 2006-05-04
JP2004506603A (ja) 2004-03-04
UA78489C2 (en) 2007-04-10
HRP20020704A2 (en) 2004-12-31
HUP0300142A2 (hu) 2003-06-28
ES2282238T3 (es) 2007-10-16
PL206041B1 (pl) 2010-06-30
NO20024223L (no) 2002-10-24
CN1418225A (zh) 2003-05-14
AU4100201A (en) 2001-09-24
EA007494B1 (ru) 2006-10-27
CZ20023098A3 (cs) 2003-02-12
KR100882081B1 (ko) 2009-02-10
YU68602A (sh) 2006-03-03
CN1418225B (zh) 2012-04-18
HK1055750A1 (en) 2004-01-21
DE60128452D1 (de) 2007-06-28
AR028518A1 (es) 2003-05-14
HU226194B1 (hu) 2008-06-30
HUP0300142A3 (en) 2005-07-28
EA200200974A1 (ru) 2003-02-27
WO2001068710A1 (en) 2001-09-20
MXPA02009091A (es) 2005-06-20
CY1108020T1 (el) 2013-09-04
SI1263790T1 (sl) 2007-10-31
ZA200206654B (en) 2003-10-20
SK13122002A3 (sk) 2003-04-01
EP1263790A1 (de) 2002-12-11
EP1263790B1 (de) 2007-05-16
NZ520944A (en) 2004-04-30
EE200200517A (et) 2004-02-16
IL151713A0 (en) 2003-04-10
DK1263790T3 (da) 2007-07-02
US20030186343A1 (en) 2003-10-02
PL358381A1 (en) 2004-08-09
US6849720B2 (en) 2005-02-01
PT1263790E (pt) 2007-06-01
DE60128452T2 (de) 2007-09-13
IL139217A0 (en) 2001-11-25
HRP20020704B1 (en) 2011-01-31
BG65762B1 (bg) 2009-10-30
SK287348B6 (sk) 2010-08-09

Similar Documents

Publication Publication Date Title
DE602004017614D1 (de) Antikörper gegen den insulinähnlichen wachstumfaktor-i-rezeptor und verwendungen dafür
DE60141855D1 (de) Antikörper gegen den rezeptor für den insulinähnlichen wachstumsfaktor i
DE60230868D1 (de) Criptoblockierende antikörper und deren verwendung
DE50212615D1 (de) Lyophilisierte zubereitung enthaltend antikörper gegen den egf-rezeptor
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
DE60142500D1 (de) Humane monoklonale Antikörper gegen das kostimulatorische Signaltransduktionsmolekül AILIM und pharmazeutische Verwendungen davon
ATE426616T1 (de) Antikírper gegen menschliches mcp-1
ATE471344T1 (de) Antikörper gegen vla-1
DE60235632D1 (de) Bicyclische verbindung, deren herstellung und verwendung
DE60105859D1 (de) Urazil Verbindungen und deren Verwendung
DE60130834D1 (de) Zusammensetzungen gegen schlechte Gerüche, deren Herstellung und Verwendung
ATE412013T1 (de) Anti-osteopontin-antikörper und dessen verwendung
DE60235547D1 (de) En daraus, deren herstellung und verwendung
ATE435872T1 (de) Anti-interleukin-1 rezeptor antikörper und deren verwendung
ATE362490T1 (de) Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung
ATE357448T1 (de) Benzoxazinonderivative, deren herstellung und verwendung
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
DE50002417D1 (de) 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
ATE392437T1 (de) Anti-idiotypische antikörper gegen antikörper, welche die bindung zwischen immunoglobulin e und seinem hochaffinitätsrezeptor hemmen
ATE329908T1 (de) Arylethene-sulfonamid derivate, deren herstellung und deren verwendung als endothelin-antagonisten
DE60002866D1 (de) Echinocandinderivate, deren herstellung und verwendung als fungizid
ATE391504T1 (de) Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten
DE50005841D1 (de) 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
DE50203525D1 (de) Tetrahydroisochinoline, ihre herstellung und verwendung als schmerzmittel
DE60116576D1 (de) Thexylchlorsilane, deren Herstellung und Verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1263790

Country of ref document: EP

EEFA Change of the company name